Showing 1381-1390 of 1697 results for "".
- Indirect Treatment Comparison Between Ingrezza and Austedo to Treat Chorea Associated with Huntington Diseasehttps://practicalneurology.com/news/indirect-treatment-comparison-between-ingrezza-and-autesto-to-treat-chorea-associated-with-huntington-disease/2470278/Ingrezza (valbenazine; Neurocrine Biosciences, San Diego, CA) may provide more benefit in early treatment of chorea symptoms associated with Huntington disease (HD) than Austedo (deutetrabenazine; Teva Pharmaceuticals, Tel Aviv, Israel), according to results of a study presented at the 2023 Inter
- Large Scandinavian Study Finds Many Antiseizure Medications Associated with Low Birth Weight in Infantshttps://practicalneurology.com/news/large-scandanavian-study-finds-many-antiseizure-medications-associated-with-low-birth-weight-in-infants/2470078/Results from the largest study to date on antiseizure medications and birth weight presented at the American Epilepsy Society Annual Meeting reveal that lamotrigine was not associated with either birth defects or low birth weight. Other agents studied, such as carbamazepine, oxcarbazepine, and to
- Muscular Dystrophy Association and Magic Wheelchair Launch 2022 Halloween Costume Competition to Raise Neuromuscular Disease Awarenesshttps://practicalneurology.com/news/muscular-dystrophy-association-and-magic-wheelchair-launch-2022-halloween-costume-competition-to-raise-neuromuscular-disease-awareness/2469729/The Muscular Dystrophy Association (MDA) and Magic Wheelchair have launched a Instagram competition to win a Magic Wheelchair Halloween costume in 2022. To enter, participants with neuromuscular diseases need to follow@MDAorg and @MagicWheelchair on Instagram and comment with a purple heart on al
- First Doses Given in Clinical Trial of Antisense Oligonucleotide for C9orf72-Associated Amyotrophic Lateral Sclerosis and Frontotemporal Dementiahttps://practicalneurology.com/news/first-doses-given-in-clinical-trial-of-antisense-oligonucleotide-for-emc9orf72em-associated-amyotrophic-lateral-sclerosis-and-frontotemporal-dementia/2469640/Multiple participants have had initial doses of an antisense oligonucleotide (ASO) (WVE-004; Wave Life Sciences, Cambridge, MA) being evaluated for treatment of C9orf72-associated amyotrophic lateral sclerosis (C9-ALS) and frontotemporal dementia (C9-FTD). This ASO is designed to
- Novel Proteomics Study Shows New Evidence of Association between NfL and MS Progression along with 11 CSF Proteins Associated with Long-Term MS Disabilityhttps://practicalneurology.com/news/novel-proteomics-study-shows-new-evidence-of-association-between-nfl-and-ms-progression-along-with-11-csf-proteins-associated-with-long-term-ms-disability/2470334/Analysis from a proteomics study published in Nature Communications revealed that neurofilament light chain (NfL) was the most powerful predictor of multiple sclerosis (MS) activity and a combination of 11 cerebrospinal fluid (CSF) proteins was useful in predicting long-term MS disabilit
- Missed Diagnostic Opportunities Common Among Patients With Pregnancy-Associated Strokehttps://practicalneurology.com/news/missed-diagnostic-opportunities-found-to-be-common-among-patients-with-pregnancy-associated-stroke/2485649/More than 1 in 4 pregnant or postpartum individuals with acute stroke experienced a missed diagnostic opportunity (MDO), according to a retrospective multicenter study published in Stroke. The findings highlight frequent diagnostic delays, which according to the study authors, suggest th
- Risk of Adult-Onset MS Associated with Maternal Pregnancy Outcomes in Studyhttps://practicalneurology.com/news/risk-of-adult-onset-ms-associated-with-maternal-pregnancy-outcomes-in-study/2485407/Individuals born large for their gestational age or exposed to maternal diabetes during pregnancy may have an increased risk for developing multiple sclerosis (MS) in adulthood, according to findings from a population-based cohort study published in JAMA Neurology. In contrast, individua
- Cell Therapy for ALS Associated with Increased Survival at 5 Yearshttps://practicalneurology.com/news/cell-therapy-for-als-shows-promise-in-increasing-survival-at-five-years/2475217/Nine out of 10 people with amyotrophic lateral sclerosis (ALS) treated with NurOwn (autologous mesenchymal stem cells [MSC]–neurotrophic factors [NTF]; BrainStorm Cell Therapeutics, New York, NY) survived more than 5 years after symptom onset. These results from an analysis of survival data from
- NMOSD Drug Associated with Favorable Outcomes in Individuals with Generalized Myasthenia Gravishttps://practicalneurology.com/news/study-finds-nmosd-drug-associated-with-favorable-outcomes-in-individuals-with-generalized-myasthenia-gravis/2473963/
- For People with Migraine, Neck Pain is Associated with Greater Disease Burdenhttps://practicalneurology.com/news/for-people-with-migraine-neck-pain-is-associated-with-greater-disease-burden/2470931/People with migraine who experience neck pain during or before headache reported more severe disease burden, according to results of a prospective, cross-sectional, web-based study. The findings, which were presented at the 18th annual European Headache Congress, may have implications for headach